Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-08ADPT144FRANCIS LO plan to sell securities of ADAPTIVE BIOTECHNOLOGIES CORPORATION under Form 144MEDIUM
FRANCIS LO filed Form 144 to notify SEC of plan to sell 22564 units of ADAPTIVE BIOTECHNOLOGIES CORPORATION securities around 2026-04-08, with aggregate market value of $309,352.44. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions...
Mid CapBiotechnology
2026-04-08ADPT144Chad Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Chad Robins filed Form 144 to notify SEC of plan to sell 37263 units of Adaptive Biotechnologies Corporation securities around 2026-04-08, with aggregate market value of $552,982.92. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transaction...
Mid CapBiotechnology
2026-04-08ADPT144Harlan Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Harlan Robins filed Form 144 to notify SEC of plan to sell 10000 units of Adaptive Biotechnologies Corporation securities around 2026-04-08, with aggregate market value of $148,400.00. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transacti...
Mid CapBiotechnology
2026-04-08ACET144OrbiMed Israel Partners II, L.P. plan to sell securities of Adicet Bio, Inc. under Form 144MEDIUM
OrbiMed Israel Partners II, L.P. filed Form 144 to notify SEC of plan to sell 40416 units of Adicet Bio, Inc. securities around 2026-04-08, with aggregate market value of $264,724.80. The total outstanding units is 9596407.0. The amount planned to be sold represents 0.42% of total outstanding units; ...
Micro CapBiotechnology
2026-04-08RCUS144JENNIFER JARRETT plan to sell securities of ARCUS BIOSCIENCES, INC. under Form 144MEDIUM
JENNIFER JARRETT filed Form 144 to notify SEC of plan to sell 70000 units of ARCUS BIOSCIENCES, INC. securities around 2026-04-08, with aggregate market value of $1,579,592.00. The total outstanding units is 125349476.0. The amount planned to be sold represents 0.06% of total outstanding units; ...
Mid CapBiotechnology